Imatinib Mesylate Tablets
Product Details:
- Indication Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumors (GIST)
- Salt Composition Imatinib Mesylate
- Dosage Form Tablet
- Feature Selective tyrosine kinase inhibitor, high bioavailability, scored tablet for easy dosing
- Ingredients Imatinib Mesylate, excipients
- Application Oral administration in indicated cancers
- Physical Color/Texture Film coated tablet, light yellow color
X
Imatinib Mesylate Tablets Product Specifications
- Selective tyrosine kinase inhibitor, high bioavailability, scored tablet for easy dosing
- Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumors (GIST)
- Oral administration in indicated cancers
- Film coated tablet, light yellow color
- 24 months
- Odorless
- Store below 30C, protected from moisture and light
- Imatinib Mesylate
- Imatinib Mesylate, excipients
- Tablet
- 100 mg and 400 mg
- 10 tablets per strip
- Varies as per supplier
- Anticancer/Oncology
- Available under brand names such as Gleevec, Imatib, Veenat, etc.
- Prescription only (Rx)
- Box, strip of tablets
- Approved by regulatory authorities such as US FDA & DCGI
- Oral
Product Description
Imatinib Mesylate Tablets are prescribed for treatment of cancer specifically CML, CLL, and certain types of gastrointestinal stromal tumors. They are anti-neoplastic agents that are considered as tyrosine kinase inhibitors that prevent phosphorylation and activation of growth receptors. Active compound of these tablets has molecular formula C30H35N7O4 with molar mass of 589.715 g/mol. They are known to show bioavailability of 98% with 95% of protein binding ability. Active chemical in these tablets go and bind to active site of tyrosine kinase and decrease its activity. Upon absorption in body, Imatinib Mesylate Tablets get metabolized in liver with help of CYP3A4 and has elimination half life of about 40 hours.
Product Details:
| Dose/Strength | 100mg, 400mg |
| Packaging Size | 30 Tablets |
| Packaging Type | Bottle |
We are leading Exporter and Manufacturer of Imatinib Tablets.
Uses
Imatinib Mesylate is used in the treatment of blood cancer (chronic myeloid leukaemia)
How it works
Imatinib Mesylate In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Imatinib Mesylate blocks this signal, and thus stops the production of these cancer cells.
Common side effects
Nausea, Rash, Vomiting, Musculoskeletal pain, Edema, Abdominal pain, Fatigue, Diarrhoea, Muscle cramp
tag
Imatinib Tablets supplier, Imatinib Tablets manufacturer in India,
Effective Targeted Therapy in Oncology
Imatinib Mesylate Tablets are renowned for their effectiveness in treating certain cancers by targeting specific tyrosine kinases involved in tumor growth. This selectivity helps minimize harm to normal cells, making Imatinib an advanced choice in the management of CML, ALL, and GIST. Each tablets scored design allows accurate dose adjustment as prescribed by healthcare professionals.
Quality and Compliance Assured
These tablets are manufactured, distributed, and exported by reputable suppliers in India, and meet rigorous standards set by regulatory authorities such as the US FDA and DCGI. Their high bioavailability ensures optimal therapeutic benefit, and a 24-month shelf life provides convenience and reliability for healthcare settings.
Easy-to-Use Oral Dosage Form
Imatinib Mesylate Tablets are administered orally, simplifying daily medication routines for patients. The film coating and light yellow color make them identifiable, while their scored design offers flexibility in dosing according to individual needs as guided by a physician.
FAQs of Imatinib Mesylate Tablets:
Q: How should Imatinib Mesylate Tablets be taken for best results?
A: Imatinib Mesylate Tablets should be swallowed whole with a full glass of water, ideally with food to reduce stomach irritation. Always take the dose exactly as prescribed by your doctor, at the same time each day, to maintain consistent blood levels.Q: What types of cancer are treated with Imatinib Mesylate Tablets?
A: Imatinib Mesylate Tablets are indicated for the treatment of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) with specific genetic abnormalities, and Gastrointestinal Stromal Tumors (GIST). Your healthcare professional will decide if Imatinib is appropriate for your condition.Q: When should I begin noticing benefits from Imatinib Mesylate Tablets?
A: The time to experience benefits can vary depending on the type and stage of cancer. Some patients may notice improvements within weeks, while for others it may take longer. Regular monitoring by your healthcare provider will help assess your response to therapy.Q: Where should I store Imatinib Mesylate Tablets to maintain their quality?
A: Store the tablets in their original packaging at temperatures below 30C, away from moisture and direct sunlight. Proper storage helps maintain the medications efficacy throughout its 24-month shelf life.Q: What is the process for obtaining Imatinib Mesylate Tablets?
A: Imatinib Mesylate Tablets are prescription-only medicines and must be prescribed by a qualified healthcare provider. Supply to patients or healthcare facilities is managed through licensed distributors, exporters, manufacturers, or wholesalers, particularly in India.Q: What are the main benefits of using Imatinib Mesylate Tablets for cancer treatment?
A: The main benefits include targeted action on cancer cells, high efficacy in treating specific leukemia and tumor types, and convenient oral administration. The scored tablets also allow for flexible dosing as per medical advice, enhancing treatment personalization.Q: How should I handle missed doses or accidental overuse of Imatinib Mesylate Tablets?
A: If you miss a dose, take it as soon as you remember unless its almost time for the next dosenever double up. In case of accidental overuse, seek immediate medical attention. For any uncertainties, always consult your healthcare provider promptly.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anticancer Drugs' category
We deal in bulk foreign inquiries.
ACTIZA PHARMACEUTICAL PRIVATE LIMITED
GST : 24AAPCA8809B1ZQ
GST : 24AAPCA8809B1ZQ
Contact Details
- 245-405, Royal Square, Utran, Surat - 394105, Gujarat, India
- Phone : 07971189326
- Mr Milan Sojitra (BDM)
- Mobile : 07971189326
|
ACTIZA PHARMACEUTICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
